Village Farms Reports Strong Q1 Profitability, 27% Revenue Growth, and Positive US Cannabis Rescheduling News

summarizeSummary

Village Farms International reported a profitable Q1 with 27% revenue growth, driven by strong international cannabis sales, alongside positive debt management and share repurchase activity. A subsequent event regarding potential US cannabis rescheduling could be a significant tailwind.

check_boxKey Events

• Strong Q1 Financial Performance

  Revenue increased 27% year-over-year to $50.2 million, gross profit surged 48% to $21.0 million, and the company achieved a net income of $2.9 million, a significant turnaround from a $6.7 million loss in the prior year. Adjusted EBITDA from continuing operations grew 118% to $9.9 million.

• Record International Cannabis Sales

  International export sales from Canada soared 171% year-over-year to a record $14.6 million, now accounting for 29% of total revenue. This growth was primarily driven by increased export volumes to Germany.

• Strategic Debt Management and Capital Allocation

  The company extended its FCC Term Loan maturity to February 2031 and reduced the interest rate by 50 basis points. It also amended and extended its Pure Sunfarms Secured Credit Facility, increasing loan commitments by C$15 million and extending maturities to February 2029. Additionally, the company repurchased 2.06 million shares for $6.37 million during the quarter.

• US Cannabis Rescheduling Executive Order

  Subsequent to the quarter-end, President Trump issued an executive order on April 23, 2026, to immediately place FDA-approved and state-licensed medical marijuana products in Schedule III of the Controlled Substances Act. An expedited administrative hearing for broader rescheduling from Schedule I to Schedule III is expected to commence on June 29, 2026, which the company believes will be beneficial.

auto_awesomeAnalysis

Village Farms International delivered a strong first quarter, marked by a significant turnaround to profitability and robust revenue growth, particularly in its international cannabis segment. The company's strategic debt management and ongoing share repurchase program further bolster its financial position. The disclosure of President Trump's executive order on cannabis rescheduling in the US is a major potential positive for the company, as it could fundamentally alter the regulatory landscape and open new market opportunities. Investors will be watching for further developments on the rescheduling process and its impact on the company's US cannabis operations.